NASDAQ · Healthcare · Biotechnology
Mineralys Therapeutics, Inc.
MLYS
Mineralys Therapeutics, Inc. CEO Jon Congleton · Market cap $1.8B.
$27.23
-2.03 · -6.94%
52w hi $47.6552w lo $12.59
Off 52w high 42.3%
62
NOTABLE
Current InsiderScore
Corp · 90d
2
2 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
3
2 strong · 1 notable
Analyst consensus
Strong Buy
Avg PT $46.00
Section 01
Recent Form 4 filings
11 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Mar 30 | RA CAPITAL MANAGEMENT, L.P. | Buy | 58,300 | $24.16 | +$1.41M | 56 | |
| Mar 27 | RA CAPITAL MANAGEMENT, L.P. | Buy | 310,700 | $23.67 | +$7.35M | 62 | |
| Nov 20 | Brian Taylor Slingsby | Sell | 1,000,000 | $43.35 | −$43.35M | 35 | |
| Nov 11 | Jon Congleton | Chief Executive Officer | Sell | 112,275 | $45.83 | −$5.15M | 54 |
| Nov 11 | Adam Scott Levy | CFO and Secretary | Sell | 38,900 | $45.93 | −$1.79M | 38 |
| Nov 11 | Adam Scott Levy | CFO and Secretary | Sell | 32,718 | $46.88 | −$1.53M | 55 |
| Nov 11 | Jon Congleton | Chief Executive Officer | Sell | 29,207 | $45.20 | −$1.32M | 31 |
| Nov 11 | Jon Congleton | Chief Executive Officer | Sell | 32,850 | $46.89 | −$1.54M | 31 |
| Sep 04 | RA CAPITAL MANAGEMENT, L.P. | Buy | 1,176,470 | $25.50 | +$30.00M | 79 | |
| Sep 04 | Srinivas Akkaraju | Buy | 588,235 | $25.50 | +$15.00M | 82 | |
| Mar 13 | Brian Taylor Slingsby | Buy | 259,259 | $13.50 | +$3.50M | 60 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
JunJulAugSepOctNovDecJanFebMarAprMay